Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Location status: Recruiting
NCT Number: NCT02998788
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Shanghai, Shanghai Municipality, 200025, China
Location status: Recruiting
Heart failure is the main cause of cardiovascular death. The primary goal of this study is to estimate the association of lifestyle behavior (e.g., alcohol, tea and coffee consumption, sedentary behavior, smoking habit, sleep disorder and physical activity), intermediate conditions (e.g., hypertension, diabetes and dyslipidemia), genetic risk factors and circulating biomarkers with heart failure prognosis. Another goal is to improve the health status and reduce cardiovascular events and death for heart failure patients via patient education, disease monitoring and medication titration. This study planned to consecutively enroll 1,000 heart failure patients fulfilling the inclusion criteria. Each participants will be followed up for at least 5 years. The study endpoints, all-cause mortality and cardiovascular events, will be identified by directly contacting participants during the follow-up surveys, checking pertinent medical records and discharge lists from the hospitals, or checking death certificates from local vital statistics offices. The Cox proportional hazard model will be used to estimate the risk factors for health outcomes in heart failure patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
Time frame: 10 years
A composite of myocardial infarction, revascularization, stroke, rehospitalization due to heart failure and cardiovascular death
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
Contact information is provided by the study sponsor or research team.
Ruijin Hospital
Other
Acronym: REM-HF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07482943
Cardiovascular Abnormalities, Cardiovascular Diseases
Hong Kong
View Trial DetailsNCT06675552
Cardiovascular Disease, Cardiovascular Diseases
Berlin, Germany
View Trial DetailsNCT07214376
Cardiovascular Diseases, Heart Diseases
Houma, Louisiana, United States
View Trial DetailsNCT05934487
Cardiovascular Diseases, Heart Diseases
Phoenix, Arizona, United States
View Trial Details